Crystal Mackall
Oprichter bij CARGO THERAPEUTICS, INC.
Vermogen: 7 M $ op 30-04-2024
Profiel
Crystal Mackall is the founder of Lyell Immunopharma, Inc. (founded in 2018) and Cargo Therapeutics, Inc. (founded in 2019) where she holds the title of Director.
Dr. Mackall is also the founder of Link Cell Therapies, Inc. Dr. Mackall's current jobs include being a Director at UCSF Stanford Health Care, The Parker Institute For Cancer Immunotherapy, and a Member of the American Society of Clinical Investigation.
Dr. Mackall's former job was as a Professor at Stanford University School of Medicine.
Dr. Mackall completed her undergraduate degree at the University of Akron and her doctorate at Northeast Ohio Medical University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CARGO THERAPEUTICS, INC.
0.96% | 10-11-2023 | 378 424 ( 0.96% ) | 7 M $ | 30-04-2024 |
Actieve functies van Crystal Mackall
| Bedrijven | Functie | Begin |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Oprichter | 01-12-2019 |
UCSF Stanford Health Care
 UCSF Stanford Health Care Miscellaneous Commercial ServicesCommercial Services UCSF Stanford Health Care is a healthcare organization that integrates a top-tier medical school with exceptional hospitals to advance human health. The American company provides resources for finding people and locations at Stanford Medicine. | Directeur/Bestuurslid | - |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Directeur/Bestuurslid | - |
| American Society of Clinical Investigation | Corporate Officer/Principal | - |
Eerdere bekende functies van Crystal Mackall
| Bedrijven | Functie | Einde |
|---|---|---|
| Stanford University School of Medicine | Corporate Officer/Principal | - |
| LYELL IMMUNOPHARMA, INC. | Oprichter | - |
Opleiding van Crystal Mackall
| University of Akron | Undergraduate Degree |
| Northeast Ohio Medical University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| CARGO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
UCSF Stanford Health Care
UCSF Stanford Health Care Miscellaneous Commercial ServicesCommercial Services UCSF Stanford Health Care is a healthcare organization that integrates a top-tier medical school with exceptional hospitals to advance human health. The American company provides resources for finding people and locations at Stanford Medicine. | Commercial Services |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
| American Society of Clinical Investigation |